BALFAXAR
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 29 Jul 2024)
What this means for you
Registered since 30 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87648328
- Registration number
- 5593557
- Mark type
- Stylized text
- Filed
- 17 Oct 2017
- Published for opposition
- 14 Aug 2018
- Registered
- 30 Oct 2018
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, blood plasma derived products, especially prothrombin for the treatment or prevention of blood or bleeding disorders
Owner
- Octapharma AG, Lachen, CH
- Octapharma AG, Lachen, CH
- Octapharma AG, Lachen, CH
Prosecution history
- 29 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Jul 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 30 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 14 Aug 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Aug 2018 — PUBLISHED FOR OPPOSITION
- 25 Jul 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jul 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jul 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jul 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jul 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Jan 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jan 2018 — NON-FINAL ACTION E-MAILED